Physiological Sample Clauses

Physiological treatments and procedures that result in the same therapeutic effects when performed on the same body region during the same visit or office encounter.
AutoNDA by SimpleDocs
Physiological. Dynamic Test 6MWT/ISWT/CPET • Height & Weight (BMI) • Heart rate/BP • Resistance • Grip Strength • EQ-5D (QOL) • EORTC QLQ-C30 (cancer specific) • WHODAS 2.0 (Disability) • IPAQ-SF (Physical Activity) • Self-Efficacy Exercise Scale (SEE) • Complications • LOS/Mortailty/90 day hospital free period • Long-term survival Digital platform incorporated Version 1 Colorectal, Lung & Upper GI surgical cohorts Monthly performance review meetings Confirm digital platform, evaluation & ethics approval Chemo / Rad & other tumour groups Surgery Phase – launches 25th April ‘19  600 patients referred to programme  Upper GI, Lung, Colorectal  >80% attending - Initial results suggest we can improve fitness  Planning H and Neck and Transformation 2 2 year mortality MDT decision to operate 95% MDT decision to operate 2 week wait DIGITAL 2 year survival Xxxxxx Xxxxxxxxx-Xxxxxx
Physiological and pathological roles of proteases
Physiological damp and mould growth • excess cold • excess heat • asbestos and manufactured mineral fibre • biocides (e.g. damp and timber treatment products) • carbon monoxide and fuel combustion products • lead • radiation • uncombusted fuel gasvolatile organic compounds. • crowding and space • entry by intruders • lighting • noise • domestic hygiene, pests and refuse • food safetypersonal hygiene, sanitation and drainage • water supply for domestic purpose • falls associated with baths • falling on level surfaces • falling associated with stairs and steps • falling between levels • electrical hazards • fire • flames and hot surfaces • collision and entrapment • explosions • position and operability of amenities • structural collapse and failing elements The HHSRS is a technical system and is best used by persons with a technical health and safety or building construction background. The HHSRS is available at: There are a number of landlord guides to the HHSRS available through the internet that provide an understanding of HHSRS without going into its full details. One such guide provided by the Government, is entitled Housing Health and Safety Rating System – Guidance for Landlords and Property-related Professionals available at xxx.xxxxxxxxxxx.xxx.xx/xxxxxxxxxxxx/xxxxxxx/ housinghealth In practice it is very challenging for landlords to acquire the skills necessary to use the HHSRS to accurately risk-assess hazards as category 1 or 2. To help landlords to identify potential category 1 hazards and prioritise them for action a simple guide to risk-assessing hazards is provided below: The risk from a hazard is a combination of: • the likelihood of a hazard, over a 12-month period, causing harm sufficient to require some medical attention and • the potential seriousness of harm from that hazard, should harm occur. A risk assessment of a hazard that indicates high likelihood of harm, and high potential seriousness of that harm, means that the hazard may potentially be high risk and therefore in need of remedial action to reduce the risk to a more acceptable level.
Physiological data collection. Portions of the course are an ongoing research project being conducted in conjunction with the Center for the Study of Non-Symbolic Consciousness and the Transformative Technology Lab at Sofia University. As part of the study you will be required to wear physiological monitoring equipment during some of the exercises or at other times. This equipment may include but is not limited to: galvanic skin response sensors, heart rate sensors, and brainwave sensors. You must have an approved cellphone to participate in the course. This cellphone must have reliable Internet access. All physiological devices will connect to your cellphone via Bluetooth or wired connection. You will be required to run an app on your phone in a designated way, and at designated times. This app will connect to the devices and stream their data into our cloud-based data storage system.
Physiological drug targeting strategies for brain drug delivery
AutoNDA by SimpleDocs
Physiological predisposition has also been explored by other studies, including a review article by Xxxxxx Xxxxxxx on the role of viral infections in SIDS [52]. Though he did not test them, Xxxxxxx hypothesized that an interaction between infant smoke exposure, breastfeeding, and viral respiratory infections may put infants at risk for SIDS. Such a model would also explain the fact that SIDS has historically been most common in the winter months, and why SIDS appears to be related to exposure to cigarette smoke [52]. A comprehensive literature review and policy statement by the Task Force on Sudden Infant Death Syndrome in 2005 summarized the significant risk factors for SIDS and made a series of recommendations to reduce risk [40]. The study found 2.5 times greater risk for SIDS among black infants compared to their white counterparts. Additionally, black infants were almost twice as likely as white infants to be placed to sleep in the prone position (21% vs. 11%). The study also concluded that the prone sleep position, overheating, sleeping on a soft surface, maternal smoking, young maternal age, low birth weight, and male gender were significantly associated with SIDS. Interestingly, the study also identified a lack of prenatal care as a risk factor. According to the task force, as incidence of prone sleeping falls in the United States, interventions targeting these and other modifiable risk factors (such as maternal smoking) will become increasingly important [40].
Physiological slurred or rapid speech - trembling hands - persistent rhinorrhea - altered pupil dilation - somnolence - flushed face - red eyes - odor of alcohol - unsteady gait - declining health Behavioral - irritability and mood swings - isolation or avoidance of group work - pattern of absenteeism and tardiness - decreased clinical and academic productivity - fluctuating clinical and academic performance - change in dress or appearance - inappropriate responses - elaborate excuses for behavior - decreased alertness/falling asleep in class - dishonesty Procedure - student privacy and an opportunity to explain the behavior will be provided - the faculty member may request an immediate urine drug/alcohol screen at the main campus hospital or an affiliating agency - if substance abuse is suspected, the student will not be allowed to drive home and will be escorted to the Emergency Department - the faculty member, student and Xxxx will meet to review the incident(s) - the student will be referred to Occupational Health Services and/or the Employee Assistance Program for follow-up - if the student follows the prescribed treatment, follow-up and monitoring, she/he may return to the program of study without academic consequences - an appeal process is available through the grievance procedure

Related to Physiological

  • Screening After you sign and date the consent document, you will begin screening. The purpose of the screening is to find out if you meet all of the requirements to take part in the study. Procedures that will be completed during the study (including screening) are described below. If you do not meet the requirements, you will not be able to take part in the study. The study investigator or study staff will explain why. As part of screening, you must complete all of the items listed below: • Give your race, age, gender, and ethnicity • Give your medical history o You must review and confirm the information in your medical history questionnaire • Give your drug, alcohol, and tobacco use history • Give your past and current medication and treatment history. This includes any over-the-counter or prescription drugs, such as vitamins, dietary supplements, or herbal supplements, taken in the past 28 days • Height and weight will be measured • Physical exam will be done • Electrocardiogram (ECG) will be collected. An ECG measures the electrical activity of the heart • You may be tested for COVID-19 o Blood tests for human immunodeficiency virus (HIV), hepatitis B, and hepatitis C o Blood tests to see how your blood clots ▪ Fibrinogen ▪ PT/INR/aPTT o Blood tests for amylase and lipase (enzymes that help with digestion, Part B only) o Blood tests for a lipid (fats) panel (Part B only) ▪ Total cholesterol ▪ Triglycerides ▪ HDL ▪ Direct HDL o Blood tests to check your thyroid function (Part B and Part C only) ▪ TSH ▪ Free T4 o Urine to test for drugs of abuse (illegal and prescription) o Urine tests to check your albumin/ creatinine ratio o Females who have not had a period for at least 12 months in a row will have a blood hormone test to confirm they cannot have children • The study investigator may decide to do an alcohol breath test • The use of proper birth control will be reviewed (males only) • You will be asked “How do you feel?” HIV, hepatitis B, and hepatitis C will be tested at screening. If anyone is exposed to your blood during the study, you will have these tests done again. If you have a positive test, you cannot be in or remain in the study. HIV is the virus that causes acquired immunodeficiency syndrome (AIDS). If your HIV test is positive, you will be told about the results. It may take weeks or months after being infected with HIV for the test to be positive. The HIV test is not always right. Having certain infections or positive test results may have to be reported to the State Department of Health. This includes results for HIV, hepatitis, and other infections. If you have any questions about what information is required to be reported, please ask the study investigator or study staff. Although this testing is meant to be private, complete privacy cannot be guaranteed. For example, it is possible for a court of law to get health or study records without your permission.

  • Diagnostic procedures to aid the Provider in determining required dental treatment.

  • Infectious Diseases The Employer and the Union desire to arrest the spread of infectious diseases in the nursing home. To achieve this objective, the Joint Health and Safety Committee may review and offer input into infection control programs and protocols including surveillance, outbreak control, isolation, precautions, worker education and training, and personal protective equipment. The Employer will provide training and ongoing education in communicable disease recognition, use of personal protective equipment, decontamination of equipment, and disposal of hazardous waste.

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

  • Animals The Hirer shall ensure that no animals (including birds) except guide dogs are brought into the premises, other than for a special event agreed to by the Village Hall. No animals whatsoever are to enter the kitchen at any time.

  • Clinical 1.1 Provides comprehensive evidence based nursing care and individual case management to a specific group of patients/clients including assessment, intervention and evaluation. 1.2 Undertakes clinical shifts at the direction of senior staff and the Nursing Director including participation on the on-call/after-hours/weekend roster if required. 1.3 Responsible and accountable for patient safety and quality of care through planning, coordinating, performing, facilitating, and evaluating the delivery of patient care relating to a particular group of patients, clients or staff in the practice setting. 1.4 Monitors, reviews and reports upon the standard of nursing practice to ensure that colleagues are working within the scope of nursing practice, following appropriate clinical pathways, policies, procedures and adopting a risk management approach in patient care delivery. 1.5 Participates in xxxx rounds/case conferences as appropriate. 1.6 Educates patients/carers in post discharge management and organises discharge summaries/referrals to other services, as appropriate. 1.7 Supports and liaises with patients, carers, colleagues, medical, nursing, allied health, support staff, external agencies and the private sector to provide coordinated multidisciplinary care. 1.8 Completes clinical documentation and undertakes other administrative/management tasks as required. 1.9 Participates in departmental and other meetings as required to meet organisational and service objectives. 1.10 Develops and seeks to implement change utilising expert clinical knowledge through research and evidence based best practice. 1.11 Monitors and maintains availability of consumable stock. 1.12 Complies with and demonstrates a positive commitment to Regulations, Acts and Policies relevant to nursing including the Code of Ethics for Nurses in Australia, the Code of Conduct for Nurses in Australia, the National Competency Standards for the Registered Nurse and the Poisons Act 2014 and Medicines and Poisons Regulations 2016. 1.13 Promotes and participates in team building and decision making. 1.14 Responsible for the clinical supervision of nurses at Level 1 and/or Enrolled Nurses/ Assistants in Nursing under their supervision.

  • Testing Landlord shall have the right to conduct annual tests of the Premises to determine whether any contamination of the Premises or the Project has occurred as a result of Tenant’s use. Tenant shall be required to pay the cost of such annual test of the Premises; provided, however, that if Tenant conducts its own tests of the Premises using third party contractors and test procedures acceptable to Landlord which tests are certified to Landlord, Landlord shall accept such tests in lieu of the annual tests to be paid for by Tenant. In addition, at any time, and from time to time, prior to the expiration or earlier termination of the Term, Landlord shall have the right to conduct appropriate tests of the Premises and the Project to determine if contamination has occurred as a result of Tenant’s use of the Premises. In connection with such testing, upon the request of Landlord, Tenant shall deliver to Landlord or its consultant such non-proprietary information concerning the use of Hazardous Materials in or about the Premises by Tenant or any Tenant Party. If contamination has occurred for which Tenant is liable under this Section 30, Tenant shall pay all costs to conduct such tests. If no such contamination is found, Landlord shall pay the costs of such tests (which shall not constitute an Operating Expense). Landlord shall provide Tenant with a copy of all third party, non-confidential reports and tests of the Premises made by or on behalf of Landlord during the Term without representation or warranty and subject to a confidentiality agreement. Tenant shall, at its sole cost and expense, promptly and satisfactorily remediate any environmental conditions identified by such testing in accordance with all Environmental Requirements. Landlord’s receipt of or satisfaction with any environmental assessment in no way waives any rights which Landlord may have against Tenant.

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • Studies The clinical, pre-clinical and other studies and tests conducted by or on behalf of or sponsored by the Company or its subsidiaries that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus were and, if still pending, are being conducted in accordance in all material respects with all statutes, laws, rules and regulations, as applicable (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA). The descriptions of the results of such studies and tests that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus are accurate and complete in all material respects and fairly present the published data derived from such studies and tests, and each of the Company and its subsidiaries has no knowledge of other studies or tests the results of which are materially inconsistent with or otherwise call into question the results described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, neither the Company nor its subsidiaries has received any notices or other correspondence from the FDA or any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA with respect to any ongoing clinical or pre-clinical studies or tests requiring the termination or suspension of such studies or tests. For the avoidance of doubt, the Company makes no representation or warranty that the results of any studies, tests or preclinical or clinical trials conducted by or on behalf of the Company will be sufficient to obtain governmental approval from the FDA or any foreign, state or local governmental body exercising comparable authority.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!